European Pharmaceutical Review

SEPTEMBER 22, 2022

A breakthrough gene-editing therapy for human immunodeficiency virus type 1 (HIV) infection has entered first-in-human testing in what is being called “a major milestone in the search for a cure for HIV/AIDS”. EBT-101, a CRISPR-Cas9 gene editing system delivered by adenovirus-associated virus vector serotype 9 (AAV9) has been administered to the first individual in a Phase I/II trial designed to establish its safety and efficacy.

Patients 145

Patients Safety Medicine Physicians 145

Pharmaceutical Technology

SEPTEMBER 22, 2022

It is the year 2030. You have just received the results from your whole genome sequencing test, offered through your public health provider, and discovered that you have a 75% chance of developing a rare form of cancer. But you are not panicking; your genomic data was automatically uploaded, with your permission, to your electronic health record (EHR), which is fully secured with blockchain technology.

Healthcare 137

Healthcare Healthcare Electronics Healthcare Provider 137

MedCity News

SEPTEMBER 19, 2022

Much like a house of mirrors, responsibility for understanding and mitigating cyber risk in healthcare is difficult to distinguish and often depends on who you ask, especially when it comes to non-enterprise systems and devices.

Healthcare 133

Healthcare Healthcare 133

Dominic Tyer

SEPTEMBER 23, 2022

Moving from the ‘new normal’ to the ‘next normal’ and beyond, the landscape for pharma’s commercial operations continues to shift, with all stakeholders beginning to adjust to a post-pandemic world

Pharmaceutical 130

Pharmaceutical Pharma Marketing 130

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

PharmaTimes

SEPTEMBER 21, 2022

A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial

Engineering 121

Engineering 121

Integrity Solutions

SEPTEMBER 22, 2022

Growing a sales team isn’t hard. Growing a sales team that’s confident, comfortable and successful in their role… now that’s a challenge. The effectiveness of any sales team starts with the sales leaders. It’s why many experts say any L&D spending should start (not end) with investing in your leaders. Simply adding more people to the team won’t deliver the scalability and dividends you’re looking for if your sales leaders aren’t willing to put

Sales 23

Sales Leads Ethics Sales Management 23

Pharmaceutical Technology

SEPTEMBER 23, 2022

Pfizer has entered an agreement with Global Fund to deliver up to six million courses of its oral therapy, Paxlovid (nirmatrelvir tablets and ritonavir tablets), under the Covid-19 Response Mechanism (C19RM). The C19RM has been the main channel to support low- and middle-income nations in procuring Covid-19 therapies, personal protective equipment, tests and vital elements to bolster health systems.

Food and Drug Administration 111

Food and Drug Administration Food Patients Pharmaceutical 111

pharmaphorum

SEPTEMBER 21, 2022

The European Commission has followed the lead of the US FDA and approved AstraZeneca’s Tezspire as an add-on maintenance therapy for patients with severe asthma, becoming the first and only biologic that can be used in all patients, and not restricted to those with specific forms of the disease. Tezspire (tezepelumab) has been cleared for use in patients 12 years and older with severe asthma who are inadequately controlled with high dose inhaled corticosteroids plus another medicinal produ

Sales 111

Sales Patients Medicine Biopharma 111

Clarivate

SEPTEMBER 21, 2022

Clarivate draws on Web of Science publication and citation data to produce an annual list of Citation Laureates – researchers of Nobel class whose high-impact contributions have transformed their fields and changed our world for the better. Every October, the world watches as the Nobel Assembly votes to confer their prestigious prizes. While people around the globe can’t help but speculate about who will be chosen, Clarivate is the only organization to use quantitative data in addition to qualit

Electronics 111

Electronics Medicine Leads Medical 111

MedCity News

SEPTEMBER 17, 2022

As the U.S. healthcare industry continues to advance value-based care and population health, lab testing price transparency and payment integrity programs should be a priority.

Patients 126

Patients Healthcare Healthcare 126

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmaceutical Technology

SEPTEMBER 19, 2022

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorisation for AstraZeneca ’s Evusheld (formerly AZD7442) for Covid-19 in the European Union (EU). This therapy is intended to treat adult and adolescent Covid-19 patients aged 12 years and above, who do not need additional oxygen and are at greater disease progression risk.

Medicine 111

Medicine Marketing Patients Pharmaceutical 111

pharmaphorum

SEPTEMBER 20, 2022

Findings from the litifilimab trial, undertaken by Northwell Health’s Division of Rheumatology and The Feinstein Institutes for Medical Research, have been published in the New England Journal of Medicine and show promise for those who have been diagnosed with systemic lupus erythematosus (SLE). Sponsored by Biogen Inc., data from the phase 2 LILAC (Part A) clinical trial published this month shows that the experimental lupus therapy could reduce disease activity in the joints of patients, globa

Medicine 111

Medicine Leads Medical Safety 111

PharmaTimes

SEPTEMBER 23, 2022

Link up will involve reporting on role of rapid diagnostics in taking on antimicrobial resistance

111

111

MedCity News

SEPTEMBER 22, 2022

These are the three changes health-tech needs to make to recreate Amazon, Uber or Venmo-like experiences in healthcare that will most accurately help to digitally replicate the humanized interactions that patients want:

Healthcare 124

Healthcare Healthcare Patients 124

Advertisement

Medgadget

SEPTEMBER 23, 2022

Scientists at Shanghai Tongji University in China have created a face mask that can alert the wearer to the presence of respiratory viruses in the surrounding environment, including the viruses behind COVID-19 and influenza. The mask includes aptamers, which are short sequences of DNA or RNA that can bind to protein targets. When viral particles bind to the aptamers, ion-gated transistors boost the signal so that the mask can sensitively detect small amounts of virus.

Media 108

Media Patients Healthcare Healthcare 108

European Pharmaceutical Review

SEPTEMBER 22, 2022

At Climate Week NYC GSK presented its new Sustainable Procurement Programme, announcing a fresh agenda, outlining how they will support their suppliers to succeed in their bold environmental objectives: have a net zero climate impact and a net positive impact on nature. This is an important move, as many GSK suppliers do not have easy geographical access to green infrastructure or green financing.

Transportation 105

Transportation Pharmaceutical manufacturing Biopharma Pharmaceutical 105

Healthcare Success

SEPTEMBER 20, 2022

Help Providers Win New Patients from Large Local Businesses with These Tactics. Large or dominant employers in your local communities are excellent targets of opportunity for new patients and cases. Most healthcare providers have local businesses that are (or could be) a source of new business. Whether it’s a company that's conveniently located across the street, or a dominant employer in the community, your providers want their business—here’s how you can help them win it.

Patients 104

Patients Specialization Healthcare Healthcare 104

MedCity News

SEPTEMBER 22, 2022

A Biogen drug designed for a genetically defined form of amyotrophic lateral sclerosis led to patient improvement at a 12- month analysis, according to data now published in the New England Journal of Medicine. Biogen had already filed an application seeking FDA approval of the ALS drug, tofersen; a regulatory decision is expected by January.

FDA 124

FDA Medicine Patients Biopharma 124

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmaTimes

SEPTEMBER 23, 2022

1,500 people set to receive new skin cancer treatment that reduces the risk of it returning

103

103

European Pharmaceutical Review

SEPTEMBER 20, 2022

In a recent paper, researchers demonstrated the comparability of a green high performance liquid chromatography (HPLC) for the determination and screening of typical antipsychotic drugs both in bulk and pharmaceutical formulation. Antipsychotics are used to treat a variety of serious mental disorders including schizophrenia and bipolar disorder, in which manic states may require management with multiple drugs.

Pharmaceutical 105

Pharmaceutical Medicine Management Patients 105

PM360

SEPTEMBER 23, 2022

NEW YORK, NY, September 23, 2022: PM360 , a leading life sciences marketing industry trade publication, announced the winners of their 14 th annual Trailblazer Awards during an event held at Gotham Hall in New York City on Thursday, September 22, 2022. The awards recognize outstanding companies, CEOs, products, marketers, brand managers, and cutting-edge initiatives within the pharmaceutical, biotech, medical device, and diagnostics industries.

Education 98

Education Marketing Pharmaceutical Medical 98

MedCity News

SEPTEMBER 23, 2022

Cheryl Larson, president and CEO of Midwest Business Group on Health, said employers are worried that the consolidation of healthcare companies will lead to higher costs for employers and patients. She made her comments following McKesson’s announcement that it has agreed to acquire Rx Savings Solutions, but declined to speak specifically about the deal.

Healthcare 122

Healthcare Healthcare Leads Patients 122

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Copyright Clearance Center

SEPTEMBER 23, 2022

The post For Banned Books Week 2022, A Record Year appeared first on Copyright Clearance Center.

98

98

pharmaphorum

SEPTEMBER 22, 2022

BeiGene’s BTK inhibitor Brukinsa (zanubrutinib) has become the first drug in the class to be recommended for routine NHS use in England and Wales to treat Waldenström macroglobulinaemia (WM) – a rare form of non-Hodgkin lymphoma (NHL). The final appraisal document from health technology assessment (HTA) agency NICE says that Brukinsa can be used to treat WM in adults who have had at least one prior treatment, and only if bendamustine plus rituximab therapy is also suitable.

Medicine 98

Medicine Patients Marketing Healthcare 98

European Pharmaceutical Review

SEPTEMBER 21, 2022

In its first meeting since July, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended these 12 medicines for approval: Beyfortus (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants during their first RSV season (when there is a risk of RSV infection in the community).

Medicine 98

Medicine Marketing Patients Safety 98

MedCity News

SEPTEMBER 17, 2022

Israeli medical device company Brainsway earned a positive coverage policy from Cigna for its deep transcranial magnetic stimulation to treat adult patients with OCD. Cigna joins the ranks of other major insurers who cover the device for OCD treatment — including Centene, Highmark, Blue Cross Blue Shield, Tricare and Palmetto GBA.

Insurance 122

Insurance Medical Patients 122

Advertiser: ZoomInfo

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

Competition

Copyright Clearance Center

SEPTEMBER 22, 2022

As with my earlier post in this series on the overall role of peer review in the scholarly and scientific publishing process, for Peer Review Week 2022 we are reposting our pieces in this series. And little bit of updated information on the topics we covered: * Psychology, in particular, seems to have a replicability problem ; even outside of psych, everyone knows that bad papers are still getting published (and they may even have a discoverability advantage ). * Retraction Watch is still engage

Doctors 98

Doctors Media FDA 98

PharmExec

SEPTEMBER 21, 2022

A cookieless future is on the horizon, so marketers across all industries are being forced to rethink their strategies and plan for the future. What does that entail?

Marketing 98

Marketing 98

pharmaphorum

SEPTEMBER 21, 2022

New book sets the pharmaceutical industry on a course for bridging the patient centricity optimism gap. Bridging the gulf between patient centricity ambition and reality has never been more important for pharma – luckily, this seemingly insurmountable goal isn’t as far out of reach as many envision. That’s according to Sharon Suchotliff, patient centricity lead at consultancy firm ZS Associates, which has just published a book on the art of patient involvement.

Pharma 98

Pharma Patients Management Pharmaceutical 98

MedCity News

SEPTEMBER 23, 2022

Parth Desai, a principal with Flare Capital Partners, is one of three investor judges taking part in the Pitch Perfect competition at the INVEST Digital Health conference in Dallas September 28. He shares his perspective on the firm’s investment strategy, collaborating with startups, and more. Register today!

Healthcare 121

Healthcare Healthcare Competition 121

Advertisement

Distribution